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Abstract
Background: Studies examining the association between alcohol intake and the risk of pancreatic cancer have
given inconsistent results. The purpose of this study was to summarize and examine the evidence regarding the
association between alcohol intake and pancreatic cancer risk based on results from prospective cohort studies.
Methods: We searched electronic databases consisting of PubMed, Ovid, Embase, and the Cochrane Library
identifying studies published up to Aug 2015. Only prospective studies that reported effect estimates with 95 %
confidence intervals (CIs) for the risk of pancreatic cancer, examining different alcohol intake categories compared
with a low alcohol intake category were included. Results of individual studies were pooled using a random-effects
model.
Results: We included 19 prospective studies (21 cohorts) reporting data from 4,211,129 individuals. Low-to-
moderate alcohol intake had little or no effect on the risk of pancreatic cancer. High alcohol intake was associated
with an increased risk of pancreatic cancer (risk ratio [RR], 1.15; 95 % CI: 1.06–1.25). Pooled analysis also showed that
high liquor intake was associated with an increased risk of pancreatic cancer (RR, 1.43; 95 % CI: 1.17–1.74). Subgroup
analyses suggested that high alcohol intake was associated with an increased risk of pancreatic cancer in North
America, when the duration of follow-up was greater than 10 years, in studies scored as high quality, and in studies
with adjustments for smoking status, body mass index, diabetes mellitus, and energy intake..
Conclusions: Low-to-moderate alcohol intake was not significantly associated with the risk of pancreatic cancer,
whereas high alcohol intake was associated with an increased risk of pancreatic cancer. Furthermore, liquor intake
in particular was associated with an increased risk of pancreatic cancer.
Keywords: Alcohol, Pancreatic cancer, Meta-analysis
Background
Pancreatic cancer is the fourth leading cause of cancer-
related death for both men and women worldwide, with
approximately 338,000 new cases diagnosed each year
[1]. Over the past few decades, studies have shown that
cigarette smoking, diabetes mellitus, and obesity are asso-
ciated with an increased risk of pancreatic cancer [2–4].
Therefore, lifestyle changes are suggested as a preventative
measure to reduce the incidence of pancreatic cancer.
Changes in alcohol consumption may be an additional
lifestyle change that might reduce the risk of pancreatic
cancer. However, the association between alcohol intake
and subsequent pancreatic cancer development is still
under investigation, and more concrete results may be of
great public health value given the prevalence of alcohol
intake in many populations [5].
Several studies using pooled analyses [6–8] have inves-
tigated the association between alcohol intake and pan-
creatic cancer risk, and have demonstrated that
moderate alcohol intake has no significant effect, while
high alcohol intake has been shown to be associated
with an increased risk of pancreatic cancer. In contrast,
previous cohort studies have shown no association be-
tween alcohol intake and pancreatic cancer risk [9–11].
Importantly, cigarette smoking, diabetes mellitus, and
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obesity are established risk factors for pancreatic cancer
and should be adjusted for in analyses examining alcohol
use [12]. Furthermore, inclusion of retrospective case–
control studies in analyses serves as a potential draw-
back as these studies are sensitive to confounding factors
and biases, especially recall bias. Thus, the association
between alcohol intake and pancreatic cancer risk re-
mains unclear due to a lack of supporting evidence.
Recently, additional large-scale prospective cohort
studies investigating the association between alcohol in-
take and subsequent pancreatic cancer morbidity have
been completed [13–16]. To better understand any ef-
fect of alcohol intake on subsequent pancreatic cancer
development, data from these recent studies need to be
re-evaluated and combined with data from the existing
literature. Therefore, we conducted a systematic review
and meta-analysis of pooled data from prospective co-
hort studies to assess the possible association between
alcohol intake and pancreatic cancer risk.
Methods
Data sources, search strategy, and selection criteria
This review was conducted and reported according to the
criteria for conducting and reporting meta-analysis of
observational studies in epidemiology (Additional file 1)
[17]. Any prospective study that examined the association
between alcohol intake and subsequent pancreatic cancer
risk was eligible for inclusion in this study, with no restric-
tions placed on language or publication status.
Relevant studies were identified using the following pro-
cedures. We searched electronic databases including
PubMed, Embase, Ovid, and the Cochrane Library for ar-
ticles published up to Aug 2015. Search terms examining
both medical subject headings and free-language searches
for “ethanol” OR “alcohol” OR “alcoholic beverages” OR
“drinking behavior” OR “alcohol drinking” OR “drink” OR
“liquor” OR “ethanol intake” OR “alcohol drink” OR
“ethanol drink” AND (”pancreas” OR “pancreatic”) AND
(“cancer” OR “carcinoma” OR “neoplasm”) AND (“cohort”
OR “cohort studies”) were used. Other sources included
meeting abstracts, meta-analyses, or reviews already pub-
lished on related topics. Authors were contacted for essen-
tial information from publications that were not available
in full. The medical subject heading, methods, population,
study design, exposure, and outcome variables of these ar-
ticles were used to identify the relevant studies.
The literature search was independently undertaken by
two investigators using a standardized approach. Any in-
consistencies between these investigators were identified
by the principal investigator and resolved by consensus.
We restricted our meta-analysis to prospective cohort
studies that were less likely to be subject to confounding
variables and bias than traditional case control studies.
A study was eligible for inclusion if the study had a
prospective cohort design, the study investigated the as-
sociation between alcohol intake and the risk of pancre-
atic cancer, and the authors reported effect estimates
(risk ratio [RR] or hazard ratio [HR]) and 95 % confi-
dence intervals (CIs) comparing different alcohol intake
categories with the lowest alcohol intake category.
Data collection and quality assessment
The information collected included the study group’s
name, country, study design, sample size, age at baseline,
follow-up duration, effect estimate, and covariates, all of
which were included in the fully adjusted model. We
also extracted the number of cases, persons, person-
years, the effect of different exposure categories, and
their 95 % CIs. For studies that reported several multi-
variable adjusted RRs, we selected the effect estimate
that was maximally adjusted for potential confounders.
The Newcastle-Ottawa Scale (NOS), which is compre-
hensive and has been partially validated for evaluating
the quality of observational studies in meta-analyses,
was used to evaluate methodological quality [18, 19].
The NOS is based on three subscales, selection consist-
ing of four items, comparability consisting of one item,
and outcome consisting of three items. A “star system”
(range, 0–9) has been developed for assessment [18].
Data extraction and quality assessment were independ-
ently conducted by two authors. The data was then inde-
pendently examined and adjudicated by an additional
author, while referring to the original studies.
Statistical analysis
We examined the relationship between alcohol intake and
risk of pancreatic cancer based on the effect estimate (RR
or HR) and its 95 % CI as published in each study. We used
a fixed-effect model to calculate summary RRs and 95 %
CIs for different alcohol intake levels compared with the
lowest alcohol intake level or no alcohol intake [20, 21]. We
then used a random-effects model to calculate summary
RRs and 95 % CIs for different alcohol intake levels com-
pared with the lowest alcohol intake level or no alcohol in-
take [22, 23]. We converted all measurements into grams
per day and defined one drink as 12 g of alcohol intake.
Using a semi-parametric method, we evaluated the associ-
ation between light (0–12 g per day), moderate (≥12-24 g
per day), or heavy alcohol (≥24 g per day) intake and the
risk of pancreatic cancer. The value assigned to each alco-
hol intake category was the mid-point for closed categories
and the median for open categories. Furthermore, we con-
structed a dose response curve based on the correlated nat-
ural log of RRs or HRs across alcohol intake categories, and
modeled alcohol intake by using restricted cubic splines
with three knots at fixed percentiles of 10 %, 50 %, and
90 % of the distribution [24, 25]. Heterogeneity between
studies was investigated using the I2 statistic as a measure
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of the proportion of total variation between studies that is
attributable to heterogeneity, where I2 values of 25 %, 50 %,
and 75 % were assigned as cut-off points for low, moderate,
and high degrees of heterogeneity [26–28]. Subgroup ana-
lyses were conducted based on country, duration of follow-
up, adjustment of covariates (including smoking status,
body mass index [BMI], diabetes mellitus, and energy
intake [EI]), and study quality. We also performed a sensi-
tivity analysis by eliminating individual studies from the
meta-analysis [29]. Several methods were used to check for
potential publication bias, including visually inspecting the
Funnel plots for pancreatic cancer, and using the Egger [30]
and Begg [31] tests for a statistical bias assessment. All re-
ported P values are 2-sided, and P values <0.05 were con-
sidered statistically significant for all included studies.
Statistical analyses were performed using STATA software
(version 12.0; Stata Corporation, College Station, TX, USA).
Results
Literature search
The study-selection process is illustrated in Fig. 1. We
identified 469 articles during our initial electronic
search, of which, 425 were excluded as duplicates or
irrelevant, leaving 44 potentially eligible studies to be se-
lected. After detailed evaluations, 19 prospective studies
consisting of 21 cohorts were selected for the final meta-
analysis [9–11, 13–16, 32–43]. A manual search of the
reference lists from these studies did not yield any
additional eligible studies. The general characteristics of
the included studies are presented in Table 1.
Study characteristics
In the included studies, follow-up periods for participants
ranged from six to 30 years, and had from 7132 to 1,290,000
individuals included. Nine studies (ten cohorts) were con-
ducted in the United States [11, 16, 32, 35, 36, 38–40, 42],
six (seven cohorts) in Europe [9, 13, 33, 34, 37, 43], and four
in other countries [10, 14, 15, 41]. In total, the meta-
analysis included 11,846 incident cases and more than
4,211,129 individuals. Study quality was assessed using the
NOS, with studies receiving a score ≥8 considered to be
high quality (Table 1). Overall, four cohorts had a score of
9 [14, 16, 33, 34], eight cohorts (six studies) had a score of
8 [9, 11, 13, 38, 39, 43], five cohorts had a score of 7 [10,
15, 35, 37, 41], and the remaining four cohorts had a score
of 6 [32, 36, 40, 42].
Alcohol intake and pancreatic cancer risk
In the pooled analysis (Fig. 2), low (RR, 0.97; 95 % CI, 0.89–
1.05; P = 0.389; Additional file 2: Figure S1), moderate (RR,
0.98; 95 % CI: 0.93–1.03; P= 0.513; Additional file 3: Figure
S2), and total alcohol intake (RR, 1.02; 95 % CI: 0.95–1.08;
P = 0.634; Additional file 4: Figure S3) were not associated
with pancreatic cancer risk, compared with the lowest alco-
hol intake level. However, high alcohol intake was associ-
ated with an increased risk of pancreatic cancer (RR, 1.15;
95 % CI: 1.06–1.25; P = 0.001; Additional file 5: Figure S4).
Between-study heterogeneity was moderate for total alcohol
intake (I2 = 39.4 %) and low for low (I2 = 0.0 %), moderate
(I2 = 0.0 %), and high alcohol intake (I2 = 14.5 %). Analysis
using the summary RR showed that low (RR, 0.98; 95 % CI,
0.84–1.15; P = 0.836), moderate (RR, 0.93; 95 % CI, 0.80–
1.09; P = 0.372), and total alcohol intake (RR, 1.03; 95 % CI,
0.91–1.17; P = 0.664) were not associated with pancreatic
cancer risk in men, compared with the lowest alcohol intake
level. However, high alcohol intake was associated with an
increased risk of pancreatic cancer in men (RR, 1.18; 95 %
CI: 1.00–1.39; P = 0.045). Results from men exhibited sub-
stantial heterogeneity for total alcohol intake (I2 = 48.7 %),
moderate heterogeneity for low alcohol intake (I2 = 21.2 %),
and low heterogeneity for moderate (I2 = 0.0 %) or high al-
cohol intake (I2 = 12.9 %). No significant association was
found between low, moderate, high, or total alcohol intake
and pancreatic cancer risk in women, and there was no
evidence of heterogeneity across studies in this population
(low: I2 = 0.0 %; moderate: I2 = 0.0 %; high: I2 = 0.0 %).
Types of alcohol intake and pancreatic cancer risk
Analysis based on the type of alcohol showed that, high
liquor intake was associated with an increased risk of pan-
creatic cancer in men (RR, 1.66; 95 % CI: 1.24–2.23; Fig. 3)
and in the total cohort (RR, 1.43; 95 % CI: 1.17–1.74;
Fig. 3). However, there was no significant association
between any other types of alcohol intake and risk of
pancreatic cancer.
Fig. 1 Flow diagram of the literature search andstudies
selection process
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Dose–response restricted cubic splines
A total of 13 cohorts (12 studies) were included in the
restricted cubic splines analysis examining the associ-
ation between alcohol intake and the incidence of pan-
creatic cancer. As shown in Fig. 4, we found no evidence
for a potential nonlinear relationship between alcohol in-
take and the risk of pancreatic cancer (P = 0.0874), al-
though alcohol intake greater than 15 g/day seemed to
be associated with an increased risk of pancreatic cancer.
A dose–response analysis examining the association
Table 1 Baseline characteristic of studies included
















Japan Men Cohort 46,465 94 40–79 RR 8.1 Age andsmoking status 7




Lithuania Men Cohort 7,132 77 45–59 HR 30.0 Age, smoking status, education, BMI. 8
LWLH
[32]
US Both Cohort 13,979 65 75.0 RR 9.0 Sex, age andsmoking status 6
ATBC
[33]
Finland Men Cohort 27,101 157 50–69 HR 13.0 Age and intervention 9
NLCS
[34]
Netherland Men Cohort 58,279 144 55–69 HR 13.3 Age, sex, smoking status, EI, BMI,
vegetable intake, and fruit intake
9




US Men Cohort 280,084 748 50–71 RR 7.3 Sex, smoking status, EI, energy-adjusted
saturated fat, red meat, and total folate
intake, BMI, PA, and DM
7
Women Cohort 190,597 401 50–71 RR 7.3
IWHS
[36]
US Women Cohort 33,976 66 55–69 RR 8.0 Age, smoking status 6
HPFS
[11]
US Men Cohort 51,529 130 40–75 RR 12.0 Age, smoking status, BMI, history of DM,
history of cholecysectomy, and EI
8
NHS [11] US Women Cohort 121,700 158 30–55 RR 16.0 Age, smoking status, BMI, history of DM,




US Men Cohort 453,770 3443 >30 RR 24.0 Age, sex, race/ethnicity, education, marital
status, BMI, FHPC, and history of gallstones,
DM, or smoking status
9
Women Cohort 576,697 3404 >30 RR 24.0
TGP [15] Japan Men Cohort 14,241 33 >35 HR 7.0 Age, smoking, BMI, history of DM 7
Women Cohort 16,585 18 >35 HR 7.0
EPIC [9] Europe Both Cohort 478,400 555 52.2 RR 8.9 Age, sex, centre, smoking status, height and




UK Women Cohort 1,290,000 1338 55.9 RR 7.2 Age, region, socioeconomic status, smoking




US Men Cohort 30,363 90 >15 RR 7.0 Smoking status, DM, BMI, and EI 8
Women Cohort 22,550 48 >15 RR 7.0
BCDDP
[39]
US Women Cohort 43,162 102 40–93 RR 11.0 Smoking status, DM, BMI, and EI 8
CTS [40] US Women Cohort 100,030 116 >22 RR 8.1 Smoking status, DM, BMI, and EI 6
CNBSS
[41]
Canada Women Cohort 49,654 105 40–59 RR 16.5 Smoking status, DM, BMI, and EI 7
PLCO
[42]
US Men Cohort 29,914 90 55–74 RR 6.0 Smoking status, DM, BMI, and EI 6
Women Cohort 28,315 60 55–74 RR 6.0
SMC
[43]
Swedish Women Cohort 36,630 54 49–83 RR 6.8 Smoking status, DM, BMI, and EI 8
COSM
[43]
Swedish Men Cohort 45,338 75 45–79 RR 6.8 Smoking status, DM, BMI, and EI 8
MCCS
[14]
Australia Men Cohort 14,908 28 40–69 RR 15.0 Smoking status, DM, BMI, and EI 9
Women Cohort 22,830 35 40–69 RR 15.0
*BMI body mass index, DM diabetes mellitus, EI energy intake, PA physical activity, FHPC family history of pancreatic cancer
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between alcohol intake and pancreatic cancer risk in
men was performed with seven cohorts, and found no
significant relationship between alcohol intake and the
risk of pancreatic cancer (P = 0.8450; Additional file 6:
Figure S5A). Alcohol intake rates of 25.0–55.0 g/day
seemed to be associated with an increased risk of pan-
creatic cancer, but alcohol intake rates greater than
55.0 g/day were not associated with the risk of pancre-
atic cancer. This analysis performed on data from
women, as shown in Additional file 6: Figure S5B, found
no evidence of a nonlinear relationship between alcohol
intake and the risk of pancreatic cancer based on the P
value for nonlinearity (P = 0.0524).
Subgroup analysis
We conducted subgroup analyses to minimize hetero-
geneity among the included studies and evaluated the
association between alcohol intake and risk of pancreatic
cancer in specific subpopulations (Table 2). First, we
noted that high alcohol intake was associated with an in-
creased risk of pancreatic cancer in North America;
when the duration of follow-up was greater than
10 years; in studies with adjustments for smoking status,
BMI, diabetes mellitus, and EI; and in studies scored as
high quality. Second, high alcohol intake was associated
with an increased risk of pancreatic cancer in men if the
duration of the follow-up was less than 10 years. Third,
high alcohol intake was associated with an increased risk
of pancreatic cancer in women if the follow-up duration
was greater than 10 years and if the study adjusted for
EI. Lastly, alcohol intake was associated with an in-
creased risk of pancreatic cancer in men in studies
scored as low quality.
Publication bias
After review of the funnel plots, we could not rule out the
potential for publication bias (Fig. 5). However, the Egger
[30] and Begg [31] tests showed no evidence of publica-
tion bias (Egger test, P = 0.199; Begg test, P = 0.928).
Discussion
Our meta-analysis drew exclusively from prospective
studies and explored all possible correlations between al-
cohol intake and the risk of pancreatic cancer. This large
quantitative analysis included 4,211,129 individuals from
19 prospective studies (21 cohorts) with a broad popula-
tion range. The findings of this meta-analysis suggest
that high alcohol intake is associated with an increased
risk of pancreatic cancer, but other levels of alcohol in-
take have no significant effect on this risk. The results
suggest a potential J-shaped correlation between increas-
ing alcohol intake and the risk of pancreatic cancer. Our
findings support the results of a previous pooled analysis
and provide evidence that associations might differ in
analysis of differently stratified groups. The magnitude
of association between alcohol intake and the risk of
pancreatic cancer was similar between sexes and after
adjustment for most factors. These findings need to be
Fig. 2 Summary of the relative risks for the association between alcohol intake and the risk of pancreatic cancer
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confirmed by stratified analyses adjusted for these fac-
tors in future studies.
A previous pooled analysis [7] suggested that liquor
intake greater than 45 g/day was associated with an in-
creased risk of pancreatic cancer in men, but had no sig-
nificant effect on the risk of pancreatic cancer in
women, while no associations were noted for wine or
beer intake. However, that study pooled only nested
case–control studies, and prospective cohort studies
were not included. Another important pooled analysis
[8] suggested that alcohol intake greater than 30 g/day
was associated with a modest increase in risk of pancre-
atic cancer. However, several important cohort studies
were not included in this analysis. Finally, Tramacere et
al. [6] suggested that moderate alcohol intake was not
associated with the risk of pancreatic cancer, but high al-
cohol intake was associated with an increased risk of
pancreatic cancer. It is notable that most of the
epidemiological evidence is derived from retrospective
case–control studies. In traditional case–control studies,
information that reflects past exposure is collected after
cancer is diagnosed, thus generating an inevitable recall
bias that cannot be ignored. This bias may partly explain
differences in the findings between prospective cohort
studies and retrospective case–control studies. Further-
more, several adjustment factors are themselves consid-
ered to be leading risk factors for pancreatic cancer, but
the primary aggregated results provide no information
regarding their influence on pancreatic cancer causation.
Considering the limitations of previous studies, we per-
formed a meta-analysis of prospective cohort studies to
determine the association between alcohol intake and
the incidence of pancreatic cancer. Our study raised the
probability that there are differences in this association
based on pre-defined factors influencing pancreatic
cancer.
Fig. 3 Relative risk estimates of pancreatic cancer for different type of alcohol intake
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Most of our findings are in agreement with the results
from several large cohort studies, showing the potential
association between alcohol use and pancreatic cancer
risk to be J-shaped. A study by Heinen et al. [34] sug-
gested an increased risk of pancreatic cancer for persons
with a high alcohol intake, but only observed that associ-
ation during the first 7 years of follow-up. Jiao et al. [35]
suggested that moderately increased pancreatic cancer
risk correlated with high alcohol intake, especially liquor,
but residual confounding by smoking status could not
be ruled out. Gapstur et al. [16] suggested that alcohol
intake, especially liquor intake greater than three drinks
per day, was associated with the risk of pancreatic can-
cer development independent of smoking status. Our
study found that low-to-moderate alcohol intake had no
significant effect on pancreatic cancer risk, but that high
alcohol intake especially high liquor intake, was associ-
ated with an increased risk of pancreatic cancer. There
are some possible explanations for this. First, long-term
high alcohol intake causes chronic alcoholic pancreatitis
[44], which could affect the association between high al-
cohol intake and the risk of pancreatic cancer. Second,
acetaldehyde, the main metabolite of alcohol, has been
identified as a carcinogen in several in vitro, human, and
animal studies [45, 46]. Finally, carcinogenic effects
could differ according to the type of alcoholic beverages,
where the association of liquor intake with pancreatic
cancer risk may be due to a dosage effect because a
drink of liquor contains a substantially higher concentra-
tion of alcohol than a drink of beer or wine [34, 47, 48].
Subgroup analyses suggested that high alcohol intake
was associated with an increased risk of pancreatic can-
cer in several subpopulations. However, no significant
association between alcohol intake and the risk of
pancreatic cancer was found in each of the correspond-
ing subpopulations. First, our study indicated that high
liquor intake was associated with an increased risk of
pancreatic cancer. The reason for this could be that the
higher percentage of liquor intake in North America
compared to populations from other countries. Second,
we noted heavy alcohol intake was associated with
increased risk of pancreatic cancer in men, while no sig-
nificant effect was observed in women. This may have to
do with the fact that far fewer women are heavy drinkers
compared to men. Third, we noted alcohol intake was
associated with an increased risk of pancreatic cancer if
the duration of the follow-up was greater than 10 years
for the total cohort or women, but that increase was
only seen in men with a follow up of less than 10 years.
A possible reason for this may be that more men are
heavy drinkers, and the cumulative contribution of alco-
hol as a carcinogen accrues more quickly. Furthermore,
follow up periods greater than 10 years in men included
smaller cohorts with increased variability. Fourth, dia-
betes mellitus, BMI, and EI influenced the association
between alcohol intake and the risk of pancreatic cancer.
However, we could not determine the effects of these
potential confounding factors on the risk of pancreatic
cancer because they were analyzed in only a few studies.
Finally, stratified analyses for several subpopulations
may be unreliable due to the inclusion of smaller co-
horts in these subsets. Therefore, we only performed
subgroup analyses when studies adjusted for these fac-
tors, providing a relative result and a comprehensive
overview.
Three strengths of our study should be highlighted.
First, to lower the probability of selection and recall bias,
which could be of concern in retrospective case–control
Fig. 4 Dose–response analysis for curvilinear association between alcohol intake and relative risks of pancreatic cancer
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Table 2 Subgroup analysis of pancreatic cancer foralcohol intake versus the lowest intake
Subroup Light alcohol intake Moderate alcohol intake Heavy alcohol intake Total alcohol intake
Country
Men US 0.92 (0.69–1.21) 0.92 (0.77–1.11) 1.22 (0.95–1.56) 1.02 (0.83–1.25)
Europe 1.09 (0.88–1.36) 0.95 (0.62–1.46) 1.21 (0.84–1.76) 1.08 (0.90–1.30)
Other 0.64 (0.25–1.64) 1.06 (0.64–1.76) 0.89 (0.61–1.30) 0.91 (0.68–1.22)
Women US 1.00 (0.87–1.14) 1.04 (0.79–1.35) 1.27 (0.98–1.65) 1.05 (0.94–1.16)
Europe 0.91 (0.50–1.64) 0.93 (0.75–1.15) 1.17 (0.70–1.97) 1.00 (0.82–1.23)
Other 0.83 (0.60–1.13) 0.88 (0.56–1.38) 1.23 (0.66–2.29) 0.89 (0.70–1.13)
Total cohort US 0.97 (0.88–1.08) 1.00 (0.93–1.08) 1.22 (1.14–1.30)* 1.06 (0.98–1.14)
Europe 0.99 (0.85–1.15) 0.89 (0.80–1.00) 1.08 (0.91–1.27) 0.99 (0.90–1.10)
Other 0.81 (0.60–1.09) 0.95 (0.67–1.34) 0.97 (0.70–1.34) 0.90 (0.75–1.08)
Duration of follow-up (years)
Men 10 or more 1.01 (0.87–1.17) 0.89 (0.67–1.19) 1.07 (0.80–1.42) 1.00 (0.83–1.20)
<10 0.92 (0.56–1.51) 0.96 (0.79–1.17) 1.30 (1.11–1.52)* 1.06 (0.89–1.27)
Women 10 or more 0.96 (0.83–1.11) 0.93 (0.67–1.29) 1.40 (1.01–1.94)* 1.01 (0.89–1.14)
<10 0.98 (0.82–1.18) 1.01 (0.81–1.27) 1.04 (0.93–1.16) 0.99 (0.92–1.06)
Total cohort 10 or more 0.99 (0.89–1.09) 0.99 (0.91–1.08) 1.20 (1.07–1.34)* 1.02 (0.92–1.12)
<10 0.93 (0.81–1.06) 0.93 (0.85–1.03) 1.12 (0.99–1.26) 1.01 (0.93–1.10)
Adjusted smoking status
Men Yes 0.98 (0.81–1.18) 0.94 (0.80–1.11) 1.19 (1.00–1.42) 1.04 (0.90–1.19)
No 1.02 (0.73–1.43) 0.82 (0.49–1.37) 0.99 (0.59–1.67) 0.96 (0.75–1.23)
Women Yes 0.97 (0.87–1.09) 0.93 (0.83–1.04) 1.07 (0.96–1.19) 0.99 (0.93–1.06)
No - - - -
Total cohort Yes 0.96 (0.89–1.05) 0.98 (0.92–1.04) 1.16 (1.06–1.26)* 1.02 (0.95–1.08)
No 1.02 (0.73–1.43) 0.82 (0.49–1.37) 0.99 (0.59–1.67) 0.96 (0.75–1.23)
Adjusted BMI
Men Yes 0.98 (0.81–1.18) 0.93 (0.79–1.10) 1.19 (0.98–1.46) 1.03 (0.88–1.20)
No 1.02 (0.73–1.43) 0.96 (0.66–1.40) 1.01 (0.70–1.47) 1.00 (0.81–1.23)
Women Yes 0.94 (0.83–1.06) 0.90 (0.80–1.01) 1.07 (0.96–1.19) 0.97 (0.91–1.04)
No 1.18 (0.88–1.59) 1.42 (0.74–2.73) 1.20 (0.54–2.68) 1.25 (0.99–1.58)
Total cohort Yes 0.96 (0.87–1.05) 0.98 (0.93–1.04) 1.17 (1.06–1.30)* 1.02 (0.95–1.09)
No 1.00 (0.83–1.21) 1.02 (0.80–1.31) 1.00 (0.77–1.28) 1.01 (0.87–1.17)
Adjusted DM
Men Yes 0.93 (0.74–1.16) 0.92 (0.77–1.10) 1.15 (0.91–1.45) 0.99 (0.83–1.18)
No 1.08 (0.85–1.37) 1.00 (0.68–1.49) 1.11 (0.83–1.53) 1.06 (0.90–1.26)
Women Yes 0.91 (0.80–1.04) 0.93 (0.74–1.17) 1.27 (0.99–1.64) 0.97 (0.87–1.07)
No 1.18 (0.94–1.49) 1.13 (0.78–1.65) 1.03 (0.92–1.16) 1.11 (0.91–1.34)
Total cohort Yes 0.91 (0.83–1.01) 1.00 (0.94–1.06) 1.20 (1.12–1.28)* 0.99 (0.91–1.07)
No 1.11 (0.95–1.30) 1.02 (0.83–1.25) 1.05 (0.94–1.17) 1.06 (0.95–1.18)
Adjusted EI
Men Yes 0.89 (0.72–1.10) 0.87 (0.73–1.04) 1.21 (0.96–1.52) 0.98 (0.81–1.18)
No 1.12 (0.92–1.36) 1.10 (0.82–1.48) 1.08 (0.84–1.40) 1.10 (0.94–1.29)
Women Yes 0.97 (0.84–1.11) 0.94 (0.75–1.18) 1.36 (1.05–1.75)* 1.02 (0.92–1.13)
No 0.97 (0.74–1.27) 1.11 (0.77–1.60) 1.02 (0.91–1.14) 1.00 (0.87–1.15)
Total cohort Yes 0.94 (0.84–1.04) 0.89 (0.78–1.03) 1.30 (1.14–1.47)* 1.00 (0.92–1.10)
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studies, only prospective cohort studies were included.
Second, the large sample size provided a more robust
quantitatively assessment of the association of alcohol
intake with the risk of pancreatic cancer, than that of
any individual study. Third, the dose–response ana-
lysis included a wide range of alcohol intake rates,
which allowed for an accurate assessment of the re-
lationship between alcohol intake dosage and pancre-
atic cancer risk.
The limitations of our study are as follows. First,
the adjusted models are different between included
studies, and the factors included in these models
might play an important role in pancreatic cancer de-
velopment. Second, in a meta-analysis of published
studies, publication bias is inevitable. Third, hetero-
geneity among studies can be another limitation of
our meta-analysis. We applied a random-effect model
that considers possible heterogeneity and preformed
subgroup analyses based on different alcohol categor-
ies to further explore sources of heterogeneity.
Finally, the analysis used pooled data (individual data
were not available), which restricted us from perform-
ing a more detailed relevant analysis and obtaining
more comprehensive results.
Conclusion
Our study suggests that high alcohol intake, espe-
cially liquor intake, might play an important role in
the risk of pancreatic cancer. According to dose–re-
sponse meta-analysis, alcohol intake greater than
15 g/day seems to be associated with an increased
pancreatic cancer incidence. Furthermore, this is a
much lower level of intake than suggested in several
of cohort studies, and this comparatively lower rec-
ommendation should be investigated further. Future
studies should focus on specific populations and
conduct stratified analyses of potential confounding
factors to obtain a more detailed analysis of the as-
sociation between alcohol intake and the risk of pan-
creatic cancer.
Fig. 5 Funnel plot for the association between alcohol intake and the risk of pancreatic cancer
Table 2 Subgroup analysis of pancreatic cancer foralcohol intake versus the lowest intake (Continued)
No 1.00 (0.89–1.14) 0.99 (0.87–1.13) 1.09 (0.99–1.21) 1.03 (0.94–1.13)
Study quality
Men 8 or 9 0.97 (0.82–1.14) 0.90 (0.72–1.13) 1.09 (0.87–1.37) 0.98 (0.83–1.16)
<8 1.20 (0.72–1.99) 0.96 (0.78–1.18) 1.22 (0.94–1.58) 1.17 (1.04–1.32)*
Women 8 or 9 0.96 (0.82–1.13) 0.99 (0.71–1.39) 1.48 (1.02–2.13) 1.01 (0.89–1.15)
<8 0.98 (0.82–1.18) 0.98 (0.80–1.20) 1.04 (0.93–1.16) 0.99 (0.92–1.06)
Total cohort 8 or 9 0.95 (0.87–1.05) 1.00 (0.94–1.06) 1.18 (1.06–1.31)* 0.99 (0.90–1.09)
<8 1.01 (0.85–1.19) 0.95 (0.84–1.08) 1.14 (0.99–1.30) 1.04 (0.96–1.13)
*BMI body mass index, DM diabetes mellitus, EI energy intake
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